Growth & profitability
- Revenue has declined 1.7% per year over the past 5 years.
Financial health
- The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $41M | -$4M | 15.1% | -9.1% | -$7M | — | $226213 |
| 2024 | $47M | $721753 | 18.8% | -3.8% | $6M | — | $5M |
| 2023 | $54M | -$20626 | 22.6% | 0.8% | $5M | — | $83696 |
| 2022 | $63M | $1M | 21.9% | 3.1% | -$5M | — | $484463 |
| 2021 | $58M | $3M | 24.6% | 6.5% | -$6M | — | $1M |
| 2020 | $45M | $3M | 27.8% | 0.0% | -$3M | — | $4M |
| 2019 | $45M | $2M | 21.9% | 0.0% | $6M | — | $10M |
| 2018 | $54M | $3M | 21.5% | 7.9% | $2M | — | $6M |
| 2017 | $48M | $3M | 23.2% | 9.3% | $3M | — | $6M |
| 2016 | — | $2M | — | — | $4M | — | $5M |
| 2015 | — | $2M | — | — | $3M | — | — |
| 2014 | — | $2M | — | — | $492713 | — | — |
| 2013 | — | $3M | — | — | $2M | — | $8M |
| 2012 | — | $3M | — | — | $4M | — | $7M |
| 2011 | — | $902394 | — | — | $2M | — | $7M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Feb '26 | $11M | -$1M | 15.7% | -10.6% | -$531629 | — | $546614 |
| Nov '25 | $9M | -$4M | -12.5% | -43.7% | -$1M | — | $1M |
| Aug '25 | $10M | -$2M | 8.2% | -13.8% | -$658036 | — | $226213 |
| May '25 | $13M | -$649634 | 15.0% | -5.5% | -$2M | — | $1M |
| Feb '25 | $9M | -$573094 | 20.1% | -8.5% | -$3M | — | $435635 |
| Nov '24 | $9M | -$658717 | 18.3% | -9.3% | -$2M | — | $3M |
| Aug '24 | $13M | -$190504 | 14.5% | -2.3% | $4M | — | $5M |
| May '24 | $16M | $154862 | 18.6% | 0.3% | -$96062 | — | $1M |
| Feb '24 | $8M | -$534145 | 25.1% | -8.8% | -$2M | — | $1M |
| Nov '23 | $10M | $1M | 19.9% | -8.0% | $5M | — | $4M |
| Aug '23 | $15M | $290221 | 20.9% | 2.7% | $4M | — | $83696 |
| May '23 | $19M | $734951 | 23.3% | 6.6% | $3M | — | $3M |
| Feb '23 | $8M | -$972038 | 23.6% | -14.9% | -$2M | — | $268389 |
| Nov '22 | $13M | -$73760 | 22.7% | -0.1% | $658019 | — | $2M |
| Aug '22 | $15M | -$208666 | 17.0% | -1.9% | $357548 | — | $484463 |
| May '22 | $21M | $1M | 25.6% | 9.7% | $2M | — | $2M |
| Feb '22 | $14M | $269820 | 24.4% | 5.0% | -$5M | — | $899055 |
| Nov '21 | $13M | -$391141 | 19.1% | -3.6% | -$2M | — | $1M |
| Aug '21 | $15M | $605114 | 19.8% | 3.6% | -$3M | — | $1M |
| May '21 | $22M | $2M | 25.8% | 12.2% | -$2M | — | $2M |
How the market has priced JCTC against its own fundamentals since 2024-10 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, JEWETT CAMERON TRADING CO LTD's revenue has declined 1.7% per year. These are computed facts, not advice.
As of FY2025, JEWETT CAMERON TRADING CO LTD reported — of total debt against $226213 of cash.
In FY2025, gross margin was 15.1%, operating margin -9.1%, and net margin -10.0%.
As of Jun '26, JEWETT CAMERON TRADING CO LTD traded at a price-to-earnings ratio of about 17.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.